"&#xa0;\nWritten Evidence submitted by UK Blood Services Joint Professional Advisory Committee (BTO0030)&#xa0;Overview\n&#xa0;&#xa0;\nProvision of bl\nood components in the United Kingdom\n&#xa0;&#xa0;\n&#xa0;\nRegulatory and policy-making arrangements\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nDonor selection, donation testing and manufacturing all contribute to product safety\n&#xa0;&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nContribution of haemovigilance \nand horizon scanning to safety\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nCurrent virus risk from transfusion\nMatching donor and patient\n&#xa0;\n&#xa0;\n&#xa0;\nAppropriate Blood Use\n/Patient \nBlood Management\n is a key contributor to safety\n&#xa0;\n&#xa0;\n&#xa0;\nMatching the supply of blood with demand\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nJanuary 2014\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n \nhttp://www.bcshguidelines.com/4_HAEMATOLOGY_GUIDELINES.html\n \nhttps://www.gov.uk/government/policy-advisory-groups/advisory-committee-on-the-safety-of-blood-tissues-and-organs\n"